GlobeNewswire 4/2/2024 Vaccinex Reports 2023 Financial Results and Provides Corporate Update
TeleTrader 3/27/2024 US opens higher after more housing data
GlobeNewswire 3/18/2024 Aspira Women’s Health Expands Senior Leadership Team with the Addition of Sandra Milligan, M.D., J.D...
GlobeNewswire 3/15/2024 American Kidney Fund Announces 2024 Class of Corporate Members Providing Support in the Fight Agains...
GlobeNewswire 3/6/2024 IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Can...
GlobeNewswire 3/5/2024 IO Biotech Announces 2023 Fourth-Quarter and Year-End Results
GlobeNewswire 3/5/2024 Sandoz announces nominations to the Board of Directors and leadership change
GlobeNewswire 2/26/2024 IO Biotech to Present at 44th Annual Cowen Health Care Conference
GlobeNewswire 2/7/2024 Alleo Labs Announces Publication on the Use of Artificial Intelligence in Neuroscience Drug Discover...
TeleTrader 2/1/2024 US opens higher, recovers from Wednesday's losses
TeleTrader 2/1/2024 Merck's Q4 sales up 6% to $14.6B
TeleTrader 1/27/2024 J&J, Merck CEOs to testify before Senate on drug prices
GlobeNewswire 1/9/2024 C4 Therapeutics Announces 2024 Priorities and Extended Cash Runway to Advance Portfolio of Targeted ...
GlobeNewswire 12/21/2023 IO Biotech Announces First Patient Dosed in Phase 2 Neoadjuvant/Adjuvant Solid Tumor Basket Trial
GlobeNewswire 12/7/2023 Compass Pathways appoints Teri Loxam as Chief Financial Officer
GlobeNewswire 12/4/2023 Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing Rule
GlobeNewswire 11/15/2023 Mural Oncology Launches to Advance Pipeline of Novel Engineered Cytokine Immunotherapies
GlobeNewswire 11/13/2023 IO Biotech Announces 2023 Third Quarter Results
GlobeNewswire 11/13/2023 Vaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate Update
GlobeNewswire 11/10/2023 IO Biotech Completes Enrollment of 380 Patients in Pivotal Phase 3 Trial in Advanced Melanoma
GlobeNewswire 11/8/2023 IO Biotech Announces Participation in Upcoming Investor Conferences
GlobeNewswire 11/8/2023 AIM ImmunoTech Announces Encouraging Translational Data from Phase 2 Study Evaluating Ampligen® for ...
GlobeNewswire 11/7/2023 Arbutus Announces CEO, William Collier, to Retire December 31, 2023
GlobeNewswire 11/6/2023 Portage Biotech Presents Updates on its iNKT and Adenosine programs at the Society for Immunotherapy...
GlobeNewswire 11/1/2023 IO Biotech Presents Three Posters at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Me...